Allianz's Analyst Likes Biogen, Celgene & Gilead
September 06, 2014 at 17:28 PM EDT
John Schroer of Allianz Global Investors spoke on CNBC's Fast Money about the biotech stocks he likes. He said that his first ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.